Follow
Chuka Nwokolo
Chuka Nwokolo
Professor of Gastroenterology, Warwick Medical School
Verified email at uhcw.nhs.uk
Title
Cited by
Cited by
Year
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ...
The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019
3452019
Plasma ghrelin following cure of Helicobacter pylori
CU Nwokolo, DA Freshwater, P O’hare, HS Randeva
Gut 52 (5), 637-640, 2003
3072003
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori.
JT Smith, RE Pounder, CU Nwokolo, S Lanzon-Miller, DG Evans, ...
Gut 31 (5), 522-525, 1990
2381990
Common variants at the MHC locus and at chromosome 16q24. 1 predispose to Barrett's esophagus
Z Su, LJ Gay, A Strange, C Palles, G Band, DC Whiteman, F Lescai, ...
Nature genetics 44 (10), 1131-1136, 2012
1812012
HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease
A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ...
Gastroenterology 158 (1), 189-199, 2020
1672020
Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
CU Nwokolo, JT Smith, C Gavey, A Sawyerr, RE Pounder
Alimentary Pharmacology & Therapeutics 4, 29-45, 1990
1601990
Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis
RP Arasaradnam, MJ McFarlane, C Ryan-Fisher, E Westenbrink, ...
PloS one 9 (9), e108750, 2014
1392014
Development and application of a new electronic nose instrument for the detection of colorectal cancer
E Westenbrink, RP Arasaradnam, N O'Connell, C Bailey, C Nwokolo, ...
Biosensors and Bioelectronics 67, 733-738, 2015
1232015
Next generation diagnostic modalities in gastroenterology–gas phase volatile compound biomarker detection
RP Arasaradnam, JA Covington, C Harmston, CU Nwokolo
Alimentary pharmacology & therapeutics 39 (8), 780-789, 2014
1212014
Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients
MM Widlak, CL Thomas, MG Thomas, C Tomkins, S Smith, N O'Connell, ...
Alimentary pharmacology & therapeutics 45 (2), 354-363, 2017
1052017
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett’s esophagus
C Palles, L Chegwidden, X Li, JM Findlay, G Farnham, FC Giner, ...
Gastroenterology 148 (2), 367-378, 2015
1052015
A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis
PM Irving, T Iqbal, C Nwokolo, S Subramanian, S Bloom, N Prasad, A Hart, ...
Inflammatory bowel diseases 24 (4), 714-724, 2018
982018
Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
A Dhaliwal, Z Zeino, C Tomkins, M Cheung, C Nwokolo, S Smith, ...
Frontline Gastroenterology 6 (1), 14-19, 2015
952015
Eradication of Helicobacter pylori abolishes 24‐hour hypergastrinaemia: a prospective study in healthy subjects
EJ Prewett, JTL Smith, CU Nwokolo, M Hudson, AM Sawyerr, RE Pounder
Alimentary pharmacology & therapeutics 5 (3), 283-290, 1991
911991
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
C Mowat, I Arnott, A Cahill, M Smith, T Ahmad, S Subramanian, S Travis, ...
The lancet Gastroenterology & hepatology 1 (4), 273-282, 2016
902016
Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non‐alcoholic steatohepatitis
A Sajjad, M Mottershead, WK Syn, R Jones, S Smith, CU Nwokolo
Alimentary pharmacology & therapeutics 22 (4), 291-299, 2005
892005
Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
CU Nwokolo, JT Smith, AM Sawyerr, RE Pounder
Gut 32 (12), 1455-1460, 1991
881991
A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease
RP Arasaradnam, N Ouaret, MG Thomas, N Quraishi, E Heatherington, ...
Inflammatory bowel diseases 19 (5), 999-1003, 2013
812013
Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
JT Smith, C Gavey, CU Nwokolo, RE Pounder
Alimentary pharmacology & therapeutics 4, 47-63, 1990
801990
Surgical resections in parous patients with distal ileal and colonic Crohn's disease.
CU Nwokolo, WC Tan, HA Andrews, RN Allan
Gut 35 (2), 220-223, 1994
771994
The system can't perform the operation now. Try again later.
Articles 1–20